7th Annual Drug Repositioning, Repurposing and Rescue Conference will Return to Chicago June 26-27
Conference sessions offer the latest findings and insights from the world’s foremost experts in repositioning and repurposing. With leaders from research and industry sitting together, new insights spur exploration and collaboration that truly impacts the advancement of medical solutions.
MINNEAPOLIS (PRWEB) April 26, 2018
Arrowhead Publishers has opened registration for the 7th Annual Drug Repositioning, Repurposing and Rescue Conference, to take place June 26-27 at the Wyndham Grand Chicago Riverfront. The conference will once again bring together leaders and high-level executives from the pharmaceutical and biotech industries to discuss key issues in drug repositioning. The Drug Repositioning Conference highlights, each year, the latest developments in the fields of drug repositioning, repurposing and rescue. As the longest-running conference in the space, the annual event has a long tradition of consistently drawing key influencers among related fields from the pharmaceutical industry, academia and research, ensuring attendees have the opportunity to learn from thought leaders and innovators while developing relationships with potential collaborators and partners.
“The conference is unique in the field for delivering value that reaches far beyond the presentations and exhibits,” said John Waslif, Managing Director of Arrowhead Publishers. “Our sessions offer the latest findings and insights from the world’s foremost experts in the fields of repositioning and repurposing. With leaders from research and industry sitting together, that’s just the beginning -- new insights spur exploration and collaboration that truly impacts the advancement of medical solutions.”
With new technologies and approaches, drug repositioning has emerged as a potentially cost-effective way to streamline the drug development process and provide new treatments to patients more quickly. Approved drugs already have met with FDA approval, so the early stages of drug development can be bypassed. By mining existing drugs for new uses, researchers can focus solely on the clinical testing portion of the approval process, shortening development timelines. Past successes have led to a more systematic approach, whereby existing compounds are being tested to identify their promise in treating both common and neglected diseases faster and with greater success.
Key themes for this year’s Drug Repositioning Conference include:
- Patient Advocacy Efforts
- New Partnerships
- Commercial Case Studies
- Collaborative Efforts
- Systematic Repositioning and Data Analytics
The conference is scheduled in collaboration with the Global Health Repurposing Awards, so conference attendees also may register to attend the awards event, which celebrates patient impact created through repurposing research. The program raises funds for Cures Within Reach, a non-profit dedicated to improving patient lives through repurposing.
There are several ways to participate in the 7th Annual Drug Repositioning, Repurposing and Rescue Conference.
Learn more at http://www.drugrepositioningconference.com.
Request conference brochure through http://www.drugrepositioningconference.com/index/download-brochure.
Explore sponsorship and exhibiting opportunities, via http://www.drugrepositioningconference.com/index/sponsorexhibit.
Apply to be considered for a speaking role at http://www.drugrepositioningconference.com/index/speaking-opportunities.
Arrowhead Publishers brings life sciences industry professionals together to help move research forward through learning, networking and professional growth. Arrowhead focuses on offering thoughtfully curated speakers, new research industry trends, case studies, emerging discoveries and the future focus of the biotech and pharmaceutical industries. Arrowhead conferences cover clinical development and cutting-edge research, regulatory issues and market dynamics, therapeutics, drug discovery and positioning, and emerging technologies for both clinicians and pharmaceutical professionals.